Strong Order Intake and Backlog Conversion
Full-year orders of $3.8 billion with more than $1.0 billion in Q4; management noted strong conversion of backlog to revenue and accelerating order synergies (captured $30 million in order synergies for 2025, more than half in Q4) that are expected to convert to revenue in 2026.
Revenue Above Guidance
Full-year consolidated revenue of $3.8 billion exceeded the high end of guidance; favorable FX translation contributed $77 million to revenue.
Margin Expansion and Adjusted EBITDA
Consolidated adjusted EBITDA of $600 million with a margin of 15.8% (at midpoint of guidance). Q4 adjusted EBITDA margin was 16.0%. Segment adjusted EBITDA margins: Protein Solutions 20.1% and Prepared Food & Beverage Solutions 17.2%.
Adjusted EPS Accretion
Full-year adjusted EPS of $6.41, representing first-year earnings accretion vs. legacy JBT 2024 adjusted EPS of $6.15 (approximately +4.2%).
Deleveraging Success and Capital Position
Leverage improved from just below 4.0x at transaction close to less than 2.9x at year-end 2025; management expects leverage of ~2.0–2.5x by end of 2026, supported by convertible financing and cash flow.
Synergy Realization and Run-Rate Savings
Realized $43 million year-over-year synergy benefit in 2025 and exited the year with approximately $85 million of run-rate savings versus 2024 baseline; company remains on track for a $150 million run-rate synergy target by exit-2027 and expects ~ $60 million incremental synergy benefit in 2026.
Confident 2026 Guidance with Strong Upside
2026 guidance: revenue growth of 5%–7% (includes ~1% FX benefit); adjusted EBITDA margins 17.0%–17.5% (midpoint +145 bps YoY); adjusted EPS guidance $8.00–$8.50 (midpoint ~+29% YoY); GAAP EPS guidance $4.70–$5.15.
End-Market Momentum — Poultry Leadership
Management highlighted a sharp recovery and robust investment in poultry equipment (poultry cited as the dominant driver across categories), plus strength in meat, beverages, pharma and improving Prepared Foods demand in Q4.